BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 31315786)

  • 1. [Therapeutic Relevance of Human Microbiota and Lung Cancer].
    Zhou H; Suo J; Zhu J
    Zhongguo Fei Ai Za Zhi; 2019 Jul; 22(7):464-469. PubMed ID: 31315786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between the lung microbiome and lung cancer.
    Mao Q; Jiang F; Yin R; Wang J; Xia W; Dong G; Ma W; Yang Y; Xu L; Hu J
    Cancer Lett; 2018 Feb; 415():40-48. PubMed ID: 29197615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiome: A Supportive or a Leading Actor in Lung Cancer?
    Martins D; Mendes F; Schmitt F
    Pathobiology; 2021; 88(2):198-207. PubMed ID: 33352574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer.
    Carbone C; Piro G; Di Noia V; D'Argento E; Vita E; Ferrara MG; Pilotto S; Milella M; Cammarota G; Gasbarrini A; Tortora G; Bria E
    Mediators Inflamm; 2019; 2019():7652014. PubMed ID: 31827379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of the Microbiome in Cancer and Therapy Efficacy: Focus on Lung Cancer.
    Halley A; Leonetti A; Gregori A; Tiseo M; Deng DM; Giovannetti E; Peters GJ
    Anticancer Res; 2020 Sep; 40(9):4807-4818. PubMed ID: 32878769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
    Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
    Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung microbiome: an emerging player in lung cancer pathogenesis and progression.
    Karvela A; Veloudiou OZ; Karachaliou A; Kloukina T; Gomatou G; Kotteas E
    Clin Transl Oncol; 2023 Aug; 25(8):2365-2372. PubMed ID: 36995519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy.
    Liu X; Cheng Y; Zang D; Zhang M; Li X; Liu D; Gao B; Zhou H; Sun J; Han X; Lin M; Chen J
    Front Oncol; 2021; 11():720842. PubMed ID: 34490119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment.
    Kennedy K; Khaddour K; Ramnath N; Weinberg F
    Cancer J; 2023 Mar-Apr 01; 29(2):61-69. PubMed ID: 36957975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research.
    McKenzie ND; Hong H; Ahmad S; Holloway RW
    Crit Rev Oncol Hematol; 2021 Jan; 157():103165. PubMed ID: 33227575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway Microbiota as a Modulator of Lung Cancer.
    Goto T
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between Gut Microbiota and Lung Cancer].
    Teng J; Zhao Y; Jiang Y; Wang Q; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):909-915. PubMed ID: 32798442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microbiome in anti-cancer therapy.
    Bashiardes S; Tuganbaev T; Federici S; Elinav E
    Semin Immunol; 2017 Aug; 32():74-81. PubMed ID: 28431920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of intestinal microbiota in response to cancer immunotherapy.
    Cong J; Zhang X
    Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2235-2240. PubMed ID: 30209679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota and Cancer: The Emerging Beneficial Role of Bifidobacteria in Cancer Immunotherapy.
    Longhi G; van Sinderen D; Ventura M; Turroni F
    Front Microbiol; 2020; 11():575072. PubMed ID: 33013813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Lung Microbiome on the Way to Cancer.
    Kovaleva OV; Romashin D; Zborovskaya IB; Davydov MM; Shogenov MS; Gratchev A
    J Immunol Res; 2019; 2019():1394191. PubMed ID: 31485458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy.
    Ocáriz-Díez M; Cruellas M; Gascón M; Lastra R; Martínez-Lostao L; Ramírez-Labrada A; Paño JR; Sesma A; Torres I; Yubero A; Pardo J; Isla D; Gálvez EM
    Front Oncol; 2020; 10():568939. PubMed ID: 33117698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress of Research on the Relationship between Lung Microbiome and Lung Cancer].
    Su Z; Jia X; Fan Y; Zhao F; Qiao Y
    Zhongguo Fei Ai Za Zhi; 2022 Jan; 25(1):40-45. PubMed ID: 35078284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism and Research Progress of Microbiome in the Development of Lung Cancer].
    Liu G; Gu A; E M
    Zhongguo Fei Ai Za Zhi; 2020 Nov; 23(11):948-953. PubMed ID: 32819055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.